F8A2 (coagulation factor VIII associated 2) is an X-linked gene encoding the HAP40 protein, which mediates endosome movement and cellular trafficking 1. The gene is located in a region associated with Factor VIII gene inversions that cause severe hemophilia A, and F8A2 is used as a molecular marker in diagnostic PCR assays to detect these inversions and identify carriers of the disease 2. F8A2 expression shows significant population variation, with levels up to 40-fold higher in African Americans compared to European Americans across multiple tissues 1, suggesting potential implications for differential cellular responses to pathogens including SARS-CoV-2 through altered endosomal dynamics. In chrX obstructive pulmonary disease (COPD), F8A2 is downregulated in peripheral blood monocytes alongside other genes involved in immune responses and reactive oxygen species protection, correlating with impaired monocyte functional activity and reduced antimicrobial defense 3. These findings suggest F8A2 participates in immune cell trafficking and function, with clinical relevance to both hemophilia diagnosis and inflammatory airway disease pathogenesis.